Advent Life Sciences

Summary

In 2010 was created Advent Life Sciences, which is appeared as VC. The company was established in Europe in United Kingdom. The main office of represented VC is situated in the London.

We also calculated 8 valuable employees in our database.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Advent Life Sciences, startups are often financed by Advent Venture Partners, Index Ventures, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Sofinnova Investments, SR One. In the next rounds fund is usually obtained by Gilde Healthcare, Advent Venture Partners, OrbiMed.

Among the most successful fund investment fields, there are Biopharma, Medical. The fund has exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Algeta, Acutus Medical, F2G. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

Opposing the other organizations, this Advent Life Sciences works on 2 percentage points more the average amount of lead investments. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2018. Speaking about the real fund results, this VC is 21 percentage points more often commits exit comparing to other organizations.